Nanomedicine Research and Education Center, Semmelweis University and Bay Zoltán Ltd., Budapest, Hungary.
Chem Phys Lipids. 2012 May;165(4):482-7. doi: 10.1016/j.chemphyslip.2011.11.012. Epub 2011 Dec 20.
In an attempt to develop a quantitative assay for supravesicular structures (SVS) - such as aggregates, fused liposomes or solid lipid particles - in liposome preparations, forward vs. side scattering of liposomal doxorubicin (Doxil/Caelyx) was analyzed by flow cytometry. Based on calibration with fluorescent latex beads, the size resolution was between about 500 and 1000 nm. Caelyx, just as structurally matched empty liposomes (Doxebo) produced dot plots clearly distinguishable from background, suggesting the presence of SVS in the above size region. A comparison of gated areas on the scattergrams obtained for different Caelyx preparations showed differences between current and expired samples, implying that SVS formation may be storage-time-dependent. Incubation of doxorubicin with Doxebo in a free drug and lipid concentration range that corresponds to that in Caelyx also led to varying SVS patterns, raising the possibility that free doxorubicin in Caelyx might contribute to SVS formation. Dynamic light scattering and transmission electron microscopic analysis of liposomes following gaiting and sorting of >500 nm particles from Caelyx confirmed the presence of SVS, providing independent evidence for their stable existence. Based on a rough estimation, the amount of SVS in Caelyx is some 60 billionth part of all liposomes. These observations raise the possibility that the presence of an exceedingly small fraction of >500 nm particles may be an intrinsic property of PEGylated small unilamellar liposomes, and that the described FACS analysis may be developed further as a quality assay for liposomal homogeneity.
为了开发一种用于检测脂质体制剂中超囊泡结构(SVS)的定量分析方法,如聚集物、融合脂质体或固体脂质颗粒,我们采用流式细胞术分析了多柔比星脂质体(Doxil/Caelyx)的前向散射和侧向散射。通过与荧光乳胶珠的校准,该方法的粒径分辨率在 500nm 到 1000nm 之间。Caelyx 和结构匹配的空脂质体(Doxebo)产生的点图明显有别于背景,表明在上述尺寸范围内存在 SVS。比较不同 Caelyx 制剂获得的散点图的门控区域表明,当前和过期样品之间存在差异,这暗示了 SVS 的形成可能与储存时间有关。在与 Caelyx 中相应的游离药物和脂质浓度范围内孵育多柔比星和 Doxebo 也导致了不同的 SVS 模式,这增加了游离多柔比星在 Caelyx 中可能有助于 SVS 形成的可能性。对脂质体进行门控和分选后,通过动态光散射和透射电子显微镜分析大于 500nm 的颗粒,证实了 SVS 的存在,为其稳定存在提供了独立的证据。根据粗略估计,Caelyx 中 SVS 的含量约为所有脂质体的 600 亿分之一。这些观察结果表明,存在非常小比例的大于 500nm 的颗粒可能是聚乙二醇化小单层脂质体的固有特性,并且可以进一步开发所描述的流式细胞术分析作为脂质体均匀性的质量分析方法。